Autobacs Seven Co. Ltd
Autobacs Seven Co., Ltd., together with its subsidiaries, engages in car-life service business in Japan and internationally. The company operates through Domestic AUTOBACS Business; Overseas Business; and Used Car Buying, Car Dealership and BtoB Business segments. Its activities include wholesale and retail of automotive related goods, as well as their installation services. The company also purc… Read more
Autobacs Seven Co. Ltd (ATBSF) - Net Assets
Latest net assets as of March 2024: $129.15 Billion USD
Based on the latest financial reports, Autobacs Seven Co. Ltd (ATBSF) has net assets worth $129.15 Billion USD as of March 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($194.95 Billion) and total liabilities ($65.80 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $129.15 Billion |
| % of Total Assets | 66.25% |
| Annual Growth Rate | -0.78% |
| 5-Year Change | 1.41% |
| 10-Year Change | N/A |
| Growth Volatility | 2.69 |
Autobacs Seven Co. Ltd - Net Assets Trend (2015–2024)
This chart illustrates how Autobacs Seven Co. Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Autobacs Seven Co. Ltd (2015–2024)
The table below shows the annual net assets of Autobacs Seven Co. Ltd from 2015 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-03-31 | $129.15 Billion | +1.72% |
| 2023-03-31 | $126.96 Billion | +3.31% |
| 2022-03-31 | $122.89 Billion | -0.76% |
| 2021-03-31 | $123.83 Billion | -2.76% |
| 2018-03-31 | $127.35 Billion | -0.03% |
| 2017-03-31 | $127.39 Billion | -3.31% |
| 2016-03-31 | $131.75 Billion | -4.91% |
| 2015-03-31 | $138.55 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Autobacs Seven Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 12.6% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $63.67 Billion | 49.42% |
| Other Components | $65.17 Billion | 50.58% |
| Total Equity | $128.84 Billion | 100.00% |
Autobacs Seven Co. Ltd Competitors by Market Cap
The table below lists competitors of Autobacs Seven Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sparindex INDEX EmMBL Akk KL A
CO:SPVIEMBLAKKKLA
|
$167.42K |
|
Eldav-L
TA:ELDAV
|
$167.48K |
|
HUDBAY MINERALS (OCKA.SG)
STU:OCKA
|
$167.60K |
|
Ivory Properties Group Bhd
KLSE:5175
|
$167.70K |
|
MSC Income Fund, Inc.
PINK:MSCF
|
$167.07K |
|
Hoegh LNG Partners LP
PINK:HMLPF
|
$167.04K |
|
Wealth Inv AKL Othania GlobAkt
CO:WEIOGA
|
$167.00K |
|
Platinum Analytics Cayman Limited Class A Ordinary Shares
NASDAQ:PLTS
|
$166.69K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Autobacs Seven Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 126,621,000,000 to 128,844,000,000, a change of 2,223,000,000 (1.8%).
- Net income of 6,355,000,000 contributed positively to equity growth.
- Dividend payments of 4,681,000,000 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $6.36 Billion | +4.93% |
| Dividends Paid | $4.68 Billion | -3.63% |
| Other Changes | $549.00 Million | +0.43% |
| Total Change | $- | 1.76% |
Book Value vs Market Value Analysis
This analysis compares Autobacs Seven Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.01x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-03-31 | $1542.38 | $17.70 | x |
| 2022-03-31 | $1572.44 | $17.70 | x |
| 2023-03-31 | $1624.43 | $17.70 | x |
| 2024-03-31 | $1652.95 | $17.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Autobacs Seven Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.93%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.76%
- • Asset Turnover: 1.18x
- • Equity Multiplier: 1.51x
- Recent ROE (4.93%) is above the historical average (4.42%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 3.33% | 2.20% | 1.12x | 1.35x | $-9.22 Billion |
| 2016 | 3.33% | 2.10% | 1.15x | 1.37x | $-8.77 Billion |
| 2017 | 2.37% | 1.48% | 1.15x | 1.39x | $-9.69 Billion |
| 2018 | 4.26% | 2.55% | 1.13x | 1.48x | $-7.28 Billion |
| 2021 | 5.72% | 3.20% | 1.17x | 1.53x | $-5.27 Billion |
| 2022 | 5.72% | 3.07% | 1.20x | 1.55x | $-5.24 Billion |
| 2023 | 5.72% | 3.06% | 1.22x | 1.53x | $-5.42 Billion |
| 2024 | 4.93% | 2.76% | 1.18x | 1.51x | $-6.53 Billion |
Industry Comparison
This section compares Autobacs Seven Co. Ltd's net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $9,496,613,978
- Average return on equity (ROE) among peers: 34.25%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Autobacs Seven Co. Ltd (ATBSF) | $129.15 Billion | 3.33% | 0.51x | $167.34K |
| Arçelik Anonim Sirketi (ACKAF) | $59.56 Billion | 12.87% | 3.33x | $19.95K |
| Argo Group US Inc. 6.5% SR NTS 42 (ARGD) | $1.23 Billion | -15.51% | 0.05x | $232.01K |
| American Crystal Sugar Company PFD REST NON DIV (ASCS) | $316.55 Million | 254.25% | 1.77x | $54.72 Million |
| Brookfield Asset Management Inc FR PRF PERPETUAL CAD 25 Ser 2 Cls A (BKFAF) | $11.77 Billion | 6.69% | 3.72x | $76.46K |
| Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) | $5.08 Billion | 14.69% | 0.67x | $9.45 Million |
| BOL Bancshares Inc. PFD (BOLBP) | $11.94 Million | 0.62% | 6.68x | $0.91 |
| NYSE LISTED TEST STOCK FOR CTS AND CQS (CBO) | $3.36 Billion | 11.17% | 0.52x | $237.68K |
| Canadian Utilities Limited 2ND PFD SER Y (CNAUF) | $4.14 Billion | 10.45% | 1.28x | $142.90K |
| Central Parking Finance Trust PFD TR CV SECS (CRLKP) | $374.10 | 13.04% | 2.96x | $224.78K |